Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (6)

« Back to Publications

A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants.

Johnson M. et al, (2024), J Infect Dis, 229, S112 - S119

Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study.

Khatami A. et al, (2012), Pediatr Infect Dis J, 31, 1069 - 1073

Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.

Khatami A. et al, (2011), Pediatr Infect Dis J, 30, 197 - 202

A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial.

Pace D. et al, (2008), Arch Dis Child, 93, 963 - 970

Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine.

Clutterbuck EA. et al, (2008), Clin Vaccine Immunol, 15, 182 - 193

A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.

Pace D. et al, (2007), Pediatr Infect Dis J, 26, 1057 - 1059